EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Clinical application of hepatic venous pressure gradient to predict early bleeding after esophageal variceal ligation



Clinical application of hepatic venous pressure gradient to predict early bleeding after esophageal variceal ligation



Zhonghua Gan Zang Bing Za Zhi 23(1): 50-54



To investigate the predictive value of hepatic venous pressure gradient (HVPG) for early bleeding after esophageal variceal ligation (EVL) by analyzing the differences in HVPG in patients with and without post-EVL bleeding. The medical records of patients who had been diagnosed with cirrhosis and esophageal varices and who had pre-EVL HVPG measurement data were surveyed. The study population included 105 patients from October 2010 to March 2014. Data of HVPG value, previous treatment history, endoscopic manifestation, and whether bleeding and serious complications occurred within 2 weeks after the ligation procedure were investigated as independent risk factors. included the chi-square test and Wilcoxon test, logistic regression modeling and receiver operating characteristic (ROC) analysis using the SPSS software version 16. Only HVPG value was identified as an independent risk factor of early bleeding after EVL.According to the ROC analysis, the area under the curve (AUC) of HVPG for early bleeding after EVL was 0.866; when HVPG was more than or equal to 16 mmHg, AUC was 0.838. The sensitivity was 90.9% and the specificity was 76.4%. HVPG is an independent factor of early bleeding after EVL and when HVPG cut-off value of more than or equal to 16 mmHg is used the predictive ability has certain accuracy and high sensitivity and specificity.

(PDF emailed within 1 workday: $29.90)

Accession: 057420024

Download citation: RISBibTeXText

PMID: 25751387



Related references

Application of a standardised protocol for hepatic venous pressure gradient measurement improves quality of readings and facilitates reduction of variceal bleeding in cirrhotics. Singapore Medical Journal 57(3): 132-137, 2016

Correlation of hepatic venous pressure gradient with variceal bleeding, size of esophageal varices, etiology, ascites and degree of liver dysfunction in cirrhosis of liver. Indian Journal of Gastroenterology 28(2): 59-61, 2010

Hepatic venous pressure gradient in cirrhosis: role in variceal bleeding, non-bleeding complications and outcome. Asian Journal of Surgery 29(3): 113-119, 2006

Clinical trial: a randomized controlled study on prevention of variceal rebleeding comparing nadolol + ligation vs. hepatic venous pressure gradient-guided pharmacological therapy. Alimentary Pharmacology & Therapeutics 29(4): 397-408, 2008

Measurement of hepatic venous pressure gradient in patients with active variceal bleeding. Hepatology 41(2): 406-7; Author Reply 407, 2005

Hepatic venous pressure gradient measurement before TIPS for acute variceal bleeding. World Journal of Gastroenterology 20(23): 7523-7524, 2015

Cost-effectiveness of hepatic venous pressure gradient measurements for prophylaxis of variceal re-bleeding. Alimentary Pharmacology & Therapeutics 19(5): 571-581, 2004

The cost effectiveness of hepatic venous pressure gradient monitoring in prevention of recurrent variceal bleeding. Gastroenterology 122(4 Suppl 1): A 79, April, 2002

A cost-effectiveness study of hepatic venous pressure gradient measurement in the secondary prevention of variceal bleeding. Revista Espanola de Enfermedades Digestivas 100(7): 416-422, 2008

Treatment of acute variceal bleeding by the hepatic venous pressure gradient Preliminary results of a randomized trial. Hepatology 30(4 PART 2): 220A, 1999

Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy. Journal of Hepatology 48(2): 229-236, 2007

Hepatic venous pressure gradient measurement in patients with liver cirrhosis: a correlation with disease severity and variceal bleeding. Medicina 45(1): 8-13, 2009

Hepatic Venous Pressure Gradient Measurement in Bangladeshi Cirrhotic Patients: A Correlation with Child's Status, Variceal Size, and Bleeding. Euroasian Journal of Hepato-Gastroenterology 7(2): 142-145, 2017

Esophageal and gastric variceal bleeding in the prevention of early rebleeding given enteral nutrition value after endoscopic variceal ligation and treatment. Zhonghua Gan Zang Bing Za Zhi 23(1): 46-49, 2015

Does a change in hepatic venous pressure gradient hvpg influence efficacy of sclerotherapy sct in prevention of recurrent esophageal variceal hemorrhage evh?. Hepatology 14(4 PART 2): 84A, 1991